Filing Details
- Accession Number:
- 0001140361-16-060673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-08 16:05:37
- Reporting Period:
- 2016-04-06
- Filing Date:
- 2016-04-08
- Accepted Time:
- 2016-04-08 16:05:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380956 | Robert Kramer | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Corporate Services Divisi | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-04-06 | 5,765 | $14.41 | 77,551 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-06 | 5,765 | $38.90 | 71,786 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 1,970 | $14.67 | 73,756 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-06 | 1,970 | $38.90 | 71,786 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 8,677 | $28.09 | 80,463 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-06 | 8,677 | $38.90 | 71,786 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-04-06 | 2,751 | $29.00 | 74,537 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-04-06 | 2,751 | $38.90 | 71,786 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-04-06 | 2,623 | $38.90 | 69,163 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Acquisiton | 2016-04-06 | 5,765 | $0.00 | 5,765 | $14.41 |
| Common Stock | Stock Option | Acquisiton | 2016-04-06 | 1,970 | $0.00 | 1,970 | $14.67 |
| Common Stock | Stock Option | Acquisiton | 2016-04-06 | 8,677 | $0.00 | 8,677 | $28.09 |
| Common Stock | Stock Option | Acquisiton | 2016-04-06 | 2,751 | $0.00 | 2,751 | $29.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-11-04 | No | 4 | M | Direct | |
| 0 | 2020-03-11 | No | 4 | M | Direct | |
| 17,354 | 2021-03-10 | No | 4 | M | Direct | |
| 22,011 | 2022-03-09 | No | 4 | M | Direct |
Footnotes
- Consists of an option granted under the company's stock incentive plan on November 5, 2012.
- Consists of an option granted under the company's stock incentive plan on March 12, 2013.
- Consists of an option granted under the company's stock incentive plan on March 11, 2014.
- Consists of an option granted under the company's stock incentive plan on March 10, 2015.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer.
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The option vested in three equal installments in November 2013, 2014 and 2015.
- The option vest in three equal installments in March 2014, 2015 and 2016.
- The option vest in three equal installments in March 2015, 2016 and 2017.
- The option vest in three equal installments in March 2016, 2017 and 2018.
Billionaire Hedge Funds
